150 related articles for article (PubMed ID: 33724031)
21. Adenosine receptors and cardiovascular disease: the adenosine-1 receptor (A1) and A1 selective ligands.
Hayes ES
Cardiovasc Toxicol; 2003; 3(1):71-88. PubMed ID: 12668891
[TBL] [Abstract][Full Text] [Related]
22. Identification of domains of the human A1 adenosine receptor that are important for binding receptor subtype-selective ligands using chimeric A1/A2a adenosine receptors.
Rivkees SA; Lasbury ME; Barbhaiya H
J Biol Chem; 1995 Sep; 270(35):20485-90. PubMed ID: 7657625
[TBL] [Abstract][Full Text] [Related]
23. Influence of incubation conditions on microsomal metabolism of xanthine-derived A
Schneider D; Bier D; Bauer A; Neumaier B; Holschbach M
J Pharmacol Toxicol Methods; 2019; 95():16-26. PubMed ID: 30476620
[TBL] [Abstract][Full Text] [Related]
24. Structures of Human A
Cheng RKY; Segala E; Robertson N; Deflorian F; Doré AS; Errey JC; Fiez-Vandal C; Marshall FH; Cooke RM
Structure; 2017 Aug; 25(8):1275-1285.e4. PubMed ID: 28712806
[TBL] [Abstract][Full Text] [Related]
25. Structure of the Adenosine A
Glukhova A; Thal DM; Nguyen AT; Vecchio EA; Jörg M; Scammells PJ; May LT; Sexton PM; Christopoulos A
Cell; 2017 Feb; 168(5):867-877.e13. PubMed ID: 28235198
[TBL] [Abstract][Full Text] [Related]
26. New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cells.
Middleton RJ; Briddon SJ; Cordeaux Y; Yates AS; Dale CL; George MW; Baker JG; Hill SJ; Kellam B
J Med Chem; 2007 Feb; 50(4):782-93. PubMed ID: 17249651
[TBL] [Abstract][Full Text] [Related]
27. Activation of the A1 adenosine receptor increases insulin-stimulated glucose transport in isolated rat soleus muscle.
Thong FS; Lally JS; Dyck DJ; Greer F; Bonen A; Graham TE
Appl Physiol Nutr Metab; 2007 Aug; 32(4):701-10. PubMed ID: 17622285
[TBL] [Abstract][Full Text] [Related]
28. Quantification of adenosine A(1) receptor biased agonism: Implications for drug discovery.
Baltos JA; Gregory KJ; White PJ; Sexton PM; Christopoulos A; May LT
Biochem Pharmacol; 2016 Jan; 99():101-12. PubMed ID: 26581123
[TBL] [Abstract][Full Text] [Related]
29. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity.
Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A
Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of methoxy substituted 2-benzoyl-1-benzofuran derivatives as lead compounds for the development adenosine A
Janse van Rensburg HD; Legoabe LJ; Terre'Blanche G; Aucamp J
Bioorg Chem; 2020 Jan; 94():103459. PubMed ID: 31818481
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Pharmacological Evaluation of Identified and Putative Metabolites of the A
Holschbach MH; Bier D; Sihver W; Schulze A; Neumaier B
ChemMedChem; 2017 May; 12(10):770-784. PubMed ID: 28217962
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of novel (benzimidazolyl)isoquinolinols and evaluation as adenosine A1 receptor tools.
Singh S; Cooper SL; Glenn JR; Beresford J; Percival LR; Tyndall JDA; Hill SJ; Kilpatrick LE; Vernall AJ
RSC Adv; 2018 Apr; 8(29):16362-16369. PubMed ID: 35542203
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of 2-benzylidene-1-tetralone derivatives as antagonists of A
Legoabe LJ; Van der Walt MM; Terre'Blanche G
Chem Biol Drug Des; 2018 Jan; 91(1):234-244. PubMed ID: 28734058
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of bivalent ligands against A(1)-D(1) receptor heteromers.
Shen J; Zhang L; Song WL; Meng T; Wang X; Chen L; Feng LY; Xu YC; Shen JK
Acta Pharmacol Sin; 2013 Mar; 34(3):441-52. PubMed ID: 23334237
[TBL] [Abstract][Full Text] [Related]
35. Novel Irreversible Agonists Acting at the A
Jörg M; Glukhova A; Abdul-Ridha A; Vecchio EA; Nguyen AT; Sexton PM; White PJ; May LT; Christopoulos A; Scammells PJ
J Med Chem; 2016 Dec; 59(24):11182-11194. PubMed ID: 27958734
[TBL] [Abstract][Full Text] [Related]
36. 2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.
Scheiff AB; Yerande SG; El-Tayeb A; Li W; Inamdar GS; Vasu KK; Sudarsanam V; Müller CE
Bioorg Med Chem; 2010 Mar; 18(6):2195-2203. PubMed ID: 20188574
[TBL] [Abstract][Full Text] [Related]
37. A
Kashfi S; Ghaedi K; Baharvand H; Nasr-Esfahani MH; Javan M
Mol Neurobiol; 2017 Dec; 54(10):8128-8139. PubMed ID: 27889899
[TBL] [Abstract][Full Text] [Related]
38. PQ-69, a novel and selective adenosine A1 receptor antagonist with inverse agonist activity.
Lu M; Wang B; Zhang C; Zhuang X; Yuan M; Wang H; Li W; Su R; Li J
Purinergic Signal; 2014 Dec; 10(4):619-29. PubMed ID: 25248972
[TBL] [Abstract][Full Text] [Related]
39. 2-Benzylidene-1-Indanone Analogues as Dual Adenosine A1/A2a Receptor Antagonists for the Potential Treatment of Neurological Conditions.
van Rensburg HJ; Legoabe L; Terre'Blanche G; Van der Walt M
Drug Res (Stuttg); 2019 Jul; 69(7):382-391. PubMed ID: 30616250
[TBL] [Abstract][Full Text] [Related]
40. Cytoskeletal protein 4.1G binds to the third intracellular loop of the A1 adenosine receptor and inhibits receptor action.
Lu D; Yan H; Othman T; Turner CP; Woolf T; Rivkees SA
Biochem J; 2004 Jan; 377(Pt 1):51-9. PubMed ID: 12974671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
